Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Virchows Archiv

• Publication date

  2016-07-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-016-1984-zPMID 27444172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens

  2015cited by this paper
• Aberrant expression of claudin-4 and -7 in hepatocytes in the cirrhotic human liver

  2015influential reference
• Pathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Increased Expression of Claudin-1 and Claudin-7 in Liver Cirrhosis and Hepatocellular Carcinoma

  2014cited by this paper
• Deafness in occludin-deficient mice with dislocation of tricellulin and progressive apoptosis of the hair cells

  2014cited by this paper
• Liver cancer

  2014cited by this paper
• Tight junction‐related human diseases

  2013cited by this paper
• Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

  2013cited by this paper
• Tricellulin expression in brain endothelial and neural cells

  2012cited by this paper
• Comparative Analysis of Immunohistochemical Markers for Differential Diagnosis of Hepatocelluar Carcinoma and Cholangiocarcinoma

  2012cited by this paper
• High expression of cancer stem cell markers in cholangiolocellular carcinoma

  2012cited by this paper
• Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation

  2012cited by this paper
• Claudin‐4‐targeted therapy using Clostridium perfringens enterotoxin for prostate cancer

  2012cited by this paper
• Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells

  2012cited by this paper
• Claudin-7 expression in hepatocellular carcinoma.

  2012cited by this paper
• Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Expression and function of claudins in hepatocytes.

  2011cited by this paper
• Negative Regulation of the Tight Junction Protein Tricellulin by Snail-Induced Epithelial-Mesenchymal Transition in Gastric Carcinoma Cells

  2010cited by this paper
• Tight Junction–associated MARVEL Proteins MarvelD3, Tricellulin, and Occludin Have Distinct but Overlapping Functions

  2010cited by this paper
• Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.

  2010cited by this paper
• Tight junction proteins and signal transduction pathways in hepatocytes.

  2009cited by this paper
• Gap and Tight Junctions in Liver: Composition, Regulation, and Function

  2009cited by this paper
• Crosstalk of tight junction components with signaling pathways.

  2008cited by this paper
• Transmembrane proteins of tight junctions.

  2008cited by this paper
• A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’

  2007cited by this paper
• Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

  2007cited by this paper
• Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas

  2006cited by this paper
• Hepatic progenitor cells in human liver tumor development.

  2006cited by this paper
• Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.

  2006cited by this paper
• Claudins: multifunctional players in epithelial tight junctions and their role in cancer

  2006cited by this paper
• Liver stem cells and their implication in hepatocellular and cholangiocarcinoma

  2006cited by this paper
• Claudins: emerging targets for cancer therapy

  2006cited by this paper
• Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro.

  2005cited by this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cited by this paper
• Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

  2005cited by this paper
• Tight junctions and human diseases

  2003cited by this paper
• Clinicopathologic study on cholangiolocellular carcinoma.

  2001cited by this paper
• Multifunctional strands in tight junctions

  2001cited by this paper
• World Health Organization classification of tumors

  2000cited by this paper
• Combined Hepatocellular-Cholangiocarcinoma

  1999cited by this paper
• Cholangiolocellular carcinoma of the liver

  1959cited by this paper
• Combined liver cell and bile duct carcinoma.

  1949cited by this paper

• IL-12 as a Potential Prognostic Marker in Penile Cancer: Implications for Immune Dysregulation

  2025cites this paper
• Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers

  2024cites this paper
• Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases

  2024cites this paper
• The Diagnostic Accuracy of Claudin-4 Immunochemistry in Differentiating Metastatic Carcinomas From Mesothelial Processes in Serous Effusion Cytology: A Systematic Review and Meta-analysis.

  2024cites this paper
• Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma

  2024cites this paper
• The Expression of the Claudin Family of Proteins in Colorectal Cancer

  2024cites this paper
• Claudins and hepatocellular carcinoma.

  2024cites this paper
• Emerging roles of transmembrane‐type tight junction proteins in cancers

  2023cites this paper
• Human Claudin-7 cis-Interactions Are Not Crucial for Membrane-Membrane (Trans-) Interactions

  2022cites this paper
• Dysregulated claudin expression significantly effect breast cancer disease progression

  2022cites this paper
• Intestinal Barrier, Claudins and Mycotoxins

  2021cites this paper
• Claudins as biomarkers of differential diagnosis and prognosis of tumors

  2021cites this paper
• A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma

  2020cites this paper
• An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin

  2020cites this paper
• Claudin-4 induction could improve the homing and anti-fibrotic effect of bone marrow mesenchymal stem cells (BM-MSCS) in thioacetamide induced liver fibrosis in rats

  2019cites this paper
• High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer

  2018cites this paper
• Functionalization of gold-nanoparticles by the Clostridium perfringens enterotoxin C-terminus for tumor cell ablation using the gold nanoparticle-mediated laser perforation technique

  2018cites this paper
• Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.

  2018cites this paper
• Occludin induces microvillus formation via phosphorylation of ezrin in a mouse hepatic cell line

  2018cites this paper